Table: Shin Nippon Biomedical -2015/16 parent results
May 13 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.58 13.27 10.20 4.41
(-27.9 pct) (+5.7 pct) (+6.5 pct) (+7.3 pct)
Operating loss 410 mln 1.15
(+48.5 pct)
Recurring loss 651 mln 2.46 30 mln loss 463 mln
(+42.3 pct)
Net 2.43 loss 969 mln 25 mln loss 643 mln
EPS 61.16 yen loss 24.38 yen 0.62 yen loss 16.16 yen
Ann Div NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T
((Tokyo Headline News Desk +813 6441 1812))